One of the leading volatility trading and derivatives investing events of the year wrapped up last month and we have lots of thoughts. From new vol dispersion products to  portfolio design, tail-risk management and structural vol; if it’s been a hot topic in 2020 – Global EQD covered it. We’re joined by Jim Carroll, Senior Vice President at Toroso Advisors and John Cummings, Director of Research at RCM Alternatives. There were sessions we agreed with, opinions from some of our favorite finfluencers,  and even some sessions that straight up made us scratch our head. So what was talked about by the likes of Benn Eifert, Chris Cole, Vineer Bhansali, PIMCO, the CBOE, and more?  Take a listen and find out.

Chapters:

00:00-02:45 = Intro

02:46-14:21 = Quick Takeaways that Caught Attention

14:22-29:54 = Learning 2020s Lessons / Tail Hedge Protection

29:55-35:20 = Largest Risks for 2021 / What Possible Grenades could be Coming?

35:21-59:56 = Vol Strategies in a Mad World

Follow along with Jim (@vixologist) & John (@cummingsjohnb) on Twitter, and make sure to keep up with the team at EQDerivatives (@EQDerivatives) so you don’t miss their next great event.

Here’s the event page over at EQD = https://eqderivatives.com/events/global-eqd-2020

And last but not least, don't forget to subscribe to The Derivative, and follow us on Twitter, or LinkedIn, and Facebook, and sign-up for our blog digest.

Disclaimer: This podcast is provided for informational purposes only and should not be relied upon as legal, business, or tax advice. All opinions expressed by podcast participants are solely their own opinions and do not necessarily reflect the opinions of RCM Alternatives, their affiliates, or companies featured. Due to industry regulations, participants on this podcast are instructed not to make specific trade recommendations, nor reference past or potential profits. And listeners are reminded that managed futures, commodity trading, and other alternative investments are complex and carry a risk of substantial losses. As such, they are not suitable for all investors. For more information, visit www.rcmalternatives.com/disclaimer